Entia Biosciences, Inc. – Trademark Portfolio
Entity Type: 03
Entia Biosciences, Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GROH and ERGOD2. The owner is based in Sherwood, OR.
Suite 800
13565 SW Tualatin-Sherwood Rd
Sherwood, OR 97140
Showing of trademarks Trademarks
Trademark Classifications
Entia Biosciences, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Entia Biosciences, Inc. have?
Entia Biosciences, Inc. has 18 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 12 cancelled.
What trademark classes does Entia Biosciences, Inc. file in?
Entia Biosciences, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Entia Biosciences, Inc.'s most well-known trademarks?
Entia Biosciences, Inc.'s registered trademark portfolio includes well-known marks such as GROH and ERGOD2. These are among 2 currently registered trademarks in the portfolio.
What is Entia Biosciences, Inc.'s trademark registration success rate?
Entia Biosciences, Inc. has a 11% trademark registration rate, with 2 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.